If so, you may have a possible legal case against the manufacturer of the potentially dangerous drug or medical product. Simply fill out the short form below and an experienced legal expert will contact you as soon as possible!

First Name:

Last Name:

Street Address:

City:

State:

Zip:

Daytime Phone Number:

Alternate Phone Number (Optional):

E-Mail Address:

Is this request for you or someone else?
Myself
My Spouse or
Minor Child
Other Relative or Friend

Drug Or Device Exposed To:

Dates Taken:

Related Health Problems Caused By The Drug:

By Clicking Above You Are Agreeing To Our Privacy Policy

Vioxx Gets Green Light To Come Back On Market

Added March 2nd, 2005

The drug that was at the center of a major scandal last year, and was subsequently withdrawn from the market, has been given the go ahead to make a comeback. Vioxx, a drug manufactured by pharmaceutical giant, Merck, was recalled from the market last autumn following evidence that it was linked to increased risk of heart attacks and strokes. However, Food and Drug Administration advisors have stated that, providing the drug carries stringent warnings, it can come back to the market.

The decision to allow Vioxx back onto the market was a narrow one, and the motion won by just two votes. If and when the drug does make a comeback, the FDA panel of advisors have confirmed that a black box warning – the most stringent warning available for drugs – must be used, enabling doctors and patients to see that the drug is associated with dangerous side effects and allowing them to make a more informed decision with regards to whether to prescribe or use it.

Panel members also stated that advertising of the drug should be restricted, as this is thought to be a powerful tool in the rising popularity and use of such drugs, and is thought to have added to the rising need and demand for this type of drug. “We want to send a very strong message that direct-to-consumer advertising is not appropriate,” stated panel chairman, Dr Alastair Wood. “It would be a brave man or a brave company that would start an ad campaign for these drugs.”

Since the FDA is usually known to go with the panel’s suggestions, it is thought that there will be no resistance to the drug being made available again, subject to the restrictions put forward by the panel. However, even panel members are wary of actually taking such drugs, with one members stating: "They would not be my first choice of drugs."

Vioxx Gets Green Light | Printable Version (Opens In New Window)

Important Notice: RYAR.org is a legal informational site.The content contained herein was not prepared by lawyers and should not be taken as a substitute for legal advice from a licensed attorney. Additionally, this information is not intended to create an attorney-client relationship simply by its viewing. The creation of an attorney-client relationship requires more than viewing this or affiliated websites. Neither the transmission nor receipt of this website material will create an attorney-client relationship between sender and receiver. The material contained herein is general in nature and may or may not be applicable to a viewer’s individual legal needs. Online readers should not act on this information without seeking professional counsel. Please read our 'Terms & Conditions Of Use' for more information.

Additionally, the information contained on RYAR.org, including but not limited to informational articles, other text/images, and on or off site links, has not been prepared, endorsed, or reviewed by any form of licensed medical professional, including but not limited to physicians, doctors, and so on. Nothing on the this website should be taken as medical advice, but instead should act as a useful resource in providing general information that may be useful to members of the general public. All visitors are encouraged to consult with a physician or other licensed medical professional for any form of medical advice. Please see our 'Terms & Conditions Of Use' for further information